CA2704771C - Sample preparation device - Google Patents
Sample preparation device Download PDFInfo
- Publication number
- CA2704771C CA2704771C CA2704771A CA2704771A CA2704771C CA 2704771 C CA2704771 C CA 2704771C CA 2704771 A CA2704771 A CA 2704771A CA 2704771 A CA2704771 A CA 2704771A CA 2704771 C CA2704771 C CA 2704771C
- Authority
- CA
- Canada
- Prior art keywords
- sample
- sample preparation
- filter
- preparation device
- opening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D39/00—Filtering material for liquid or gaseous fluids
- B01D39/14—Other self-supporting filtering material ; Other filtering material
- B01D39/20—Other self-supporting filtering material ; Other filtering material of inorganic material, e.g. asbestos paper, metallic filtering material of non-woven wires
- B01D39/2003—Glass or glassy material
- B01D39/2006—Glass or glassy material the material being particulate
- B01D39/201—Glass or glassy material the material being particulate sintered or bonded by inorganic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/02—Burettes; Pipettes
- B01L3/0275—Interchangeable or disposable dispensing tips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0631—Purification arrangements, e.g. solid phase extraction [SPE]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0681—Filter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
Abstract
A sample preparation device is disclosed. The sample preparation device includes a housing defining a passage way between a first opening and a second opening; and a sample filter occupying a section of said passage way. The sample filter contains a monolith adsorbent that specifically binds to nucleic acids. Also disclosed are sample filters containing glass frit is coated with an capture agent that binds specifically to an analyte of interest, sample filters containing a hydrophilic matrix with impregnated chemicals that lyses cell membranes, a cartridge base and an integrated sample preparation cartridge.
Description
SAMPLE PREPARATION DEVICE
TECHNICAL FIELD
The technical field is sample preparation devices in the biochemical art and, in particular, sample preparation devices using a porous monolith filter for sample filtration, separation and purification.
BACKGROUND
The presence of salts, detergents and other contaminants in a sample can be deleterious to the biochemical analysis of the sample. Many sample preparation devices have been developed in the biochemical art to remove solvent, solute and other molecules/materials from a liquid sample that contains the analyte of interest.
For example, U.S. Patent Nos. 6,048,457 and 6,200,474 describes pipette tips with chromatography media in them for the purification of proteins and peptides. The chromatography media typically consists of functionalized glass beads with C4, C18, or a strong cationic resin such as polysulfone, polyethersulfone, polytetrafluoroethylene, cellulose acetate, polystyrene, polystyrene/acrylonitrile copolymer and PVDF.
U.S.
Patent No. 6,537,502 also describes a sample purification pipette tip having a solid matrix coating on the interior surface of the pipette tip for sample separation and purification. The solid matrix is composed of a polymeric substance such as polytetrafluoroethylene, polysulfone, polyethersulfone, polystyrene, polystyrene/acrylonitrile copolymer, and polyvinylidene fluoride.
There still exists a need, however, for sample preparation devices that are easy to use and can be manufactured at low cost.
SUMMARY
A sample preparation device is disclosed. The sample preparation device includes a housing defining a passage way between a first opening and a second opening;
and a sample filter occupying a section of said passage way. The sample filter contains a monolith adsorbent that specifically binds to nucleic acids. Also disclosed are sample filters containing a glass frit, coated with a capture agent that binds specifically to an
TECHNICAL FIELD
The technical field is sample preparation devices in the biochemical art and, in particular, sample preparation devices using a porous monolith filter for sample filtration, separation and purification.
BACKGROUND
The presence of salts, detergents and other contaminants in a sample can be deleterious to the biochemical analysis of the sample. Many sample preparation devices have been developed in the biochemical art to remove solvent, solute and other molecules/materials from a liquid sample that contains the analyte of interest.
For example, U.S. Patent Nos. 6,048,457 and 6,200,474 describes pipette tips with chromatography media in them for the purification of proteins and peptides. The chromatography media typically consists of functionalized glass beads with C4, C18, or a strong cationic resin such as polysulfone, polyethersulfone, polytetrafluoroethylene, cellulose acetate, polystyrene, polystyrene/acrylonitrile copolymer and PVDF.
U.S.
Patent No. 6,537,502 also describes a sample purification pipette tip having a solid matrix coating on the interior surface of the pipette tip for sample separation and purification. The solid matrix is composed of a polymeric substance such as polytetrafluoroethylene, polysulfone, polyethersulfone, polystyrene, polystyrene/acrylonitrile copolymer, and polyvinylidene fluoride.
There still exists a need, however, for sample preparation devices that are easy to use and can be manufactured at low cost.
SUMMARY
A sample preparation device is disclosed. The sample preparation device includes a housing defining a passage way between a first opening and a second opening;
and a sample filter occupying a section of said passage way. The sample filter contains a monolith adsorbent that specifically binds to nucleic acids. Also disclosed are sample filters containing a glass frit, coated with a capture agent that binds specifically to an
2 PCT/US2008/068159 analyte of interest, and sample filters containing a hydrophilic matrix with impregnated chemicals that lyse cell membranes.
Also disclosed is an integrated sample preparation cartridge. The integrated sample preparation cartridge includes a sample preparation device and a cartridge base.
The sample preparation device includes a housing defining a passage way between a first opening and a second opening,, and a sample filter occupying a section of the passage way, the sample filter includes an adsorbent that specifically binds to an analyte of interest. The cartridge base includes a first port configured to interface with the sample preparation device, a second port configured to interface with a liquid delivery device, and a first channel connecting the first port to the second port.
Also disclosed is a sample purification system. The sample purification system includes a sample preparation device, a cartridge base and a liquid delivery device.
Also disclosed is a method for purifying an analyte from a sample. The method includes passing a sample through a sample preparation device comprising a housing defining a passage way between a first opening and a second opening, and a filter occupying a section of the passage way, wherein the sample filter comprising a material that specifically binds to said analyte and the sample passes through the sample -filter while passing through the sample preparation device; and eluting analyte bound to the sample :filter with an eluting solution, wherein the sample and the eluting solution enter and. exit the housing through the same opening, DESCRIPTION OF THE :DRAWINGS
The detailed description will refer to the following drawings, wherein like numerals refer to like elements, and wherein:
Figures A-1D are schematics of various embodiments of a sample preparation device.
Figure 2A-2C are schematics of the three-dimensional view (Figure 2A), the top view (Figure 2B) and the bottom view (Figure 2C) of an embodiment of an integrated sample preparation device.
Figure 3 shows the real-time :PCR analysis of Bacillus anthracis nucleic acids pwi ti ed from a blood sample. Controls include unprocessed Bacillus onthracis suspended in water at a concentration of 104 cfutml and NTC (no template control).
Figure 4 shows the real-time PCR analysis of Streptococcus pyogenes nucleic acids purified from samples at various Streptococcus pyogenes concentrations.
Controls
Also disclosed is an integrated sample preparation cartridge. The integrated sample preparation cartridge includes a sample preparation device and a cartridge base.
The sample preparation device includes a housing defining a passage way between a first opening and a second opening,, and a sample filter occupying a section of the passage way, the sample filter includes an adsorbent that specifically binds to an analyte of interest. The cartridge base includes a first port configured to interface with the sample preparation device, a second port configured to interface with a liquid delivery device, and a first channel connecting the first port to the second port.
Also disclosed is a sample purification system. The sample purification system includes a sample preparation device, a cartridge base and a liquid delivery device.
Also disclosed is a method for purifying an analyte from a sample. The method includes passing a sample through a sample preparation device comprising a housing defining a passage way between a first opening and a second opening, and a filter occupying a section of the passage way, wherein the sample filter comprising a material that specifically binds to said analyte and the sample passes through the sample -filter while passing through the sample preparation device; and eluting analyte bound to the sample :filter with an eluting solution, wherein the sample and the eluting solution enter and. exit the housing through the same opening, DESCRIPTION OF THE :DRAWINGS
The detailed description will refer to the following drawings, wherein like numerals refer to like elements, and wherein:
Figures A-1D are schematics of various embodiments of a sample preparation device.
Figure 2A-2C are schematics of the three-dimensional view (Figure 2A), the top view (Figure 2B) and the bottom view (Figure 2C) of an embodiment of an integrated sample preparation device.
Figure 3 shows the real-time :PCR analysis of Bacillus anthracis nucleic acids pwi ti ed from a blood sample. Controls include unprocessed Bacillus onthracis suspended in water at a concentration of 104 cfutml and NTC (no template control).
Figure 4 shows the real-time PCR analysis of Streptococcus pyogenes nucleic acids purified from samples at various Streptococcus pyogenes concentrations.
Controls
3 are unprocessed sample of Streptococcus pyogenes suspended in water at a concentration of 104 clulinl and NTC (no template control).
Figure 5 shows the real-time PCR analysis of Bacillus anthracts nucleic acids purified from a .nasopharyngeal sample. Controls are unprocessed Bacillus anthracis suspended in water at a concentration of .104 cfulmi Figure 6 shows the real-time PCR analysis of Venezuela Equine Encephalitis virus nucleic acids purified from a blood sample. Controls are unprocessed Venezuela Equine Encephalitis virus suspended in water at a concentration of 104 .pfu/m1 and NTC
(no template control). All samples are tested in duplicates.
Figure 7 is a screen shot Showing the Sample Toggle screen of the Flow Pro Fluidic Handling System Figure 8 is a screen shot showing the real time PCR result screen of a Flow Pro Fluidic Handling System (Global FlA, Fox Island, WA). Controls are unprocessed Yersinia pestis suspended in water at a concentration of 104 cfulml and NTC
(no template control).
This description is intended to be read in connection .with the. accompanying drawings, which are to be considered part of the entire written description of this invention. The drawing .figures are not necessarily to scale and certain features of the invention may be shown exaggerated in scale or in somewhat schematic form in the interest of clarity and conciseness. In the description, relative terms such as "front,"
"back," "up," "down," "top" and "bottom," as well as derivatives thereof, should be construed to refer to the orientation as then described or as shown in the drawing figure under discussion.. These relative terms are for convenience of description and normally are not intended to require a particular orientation. Terms concerning attachments, 2.5 coupling and the like, such as "connected" and "attached," refer to a relationship wherein structures are secured or attached to one another either directly or indirectly through intervening structures, as well as both movable or rigid attachments or relationships, unless expressly described otherwise.
In describing embodiments of the present invention, specific terminology is employed for the sake of clarity. However, the invention is not intended to be limited to the specific terminology so selected. It is to be understood that each specific element .includes all technical equivalents which operate in a. similar manner to accomplish a similar purpose.
Figure 5 shows the real-time PCR analysis of Bacillus anthracts nucleic acids purified from a .nasopharyngeal sample. Controls are unprocessed Bacillus anthracis suspended in water at a concentration of .104 cfulmi Figure 6 shows the real-time PCR analysis of Venezuela Equine Encephalitis virus nucleic acids purified from a blood sample. Controls are unprocessed Venezuela Equine Encephalitis virus suspended in water at a concentration of 104 .pfu/m1 and NTC
(no template control). All samples are tested in duplicates.
Figure 7 is a screen shot Showing the Sample Toggle screen of the Flow Pro Fluidic Handling System Figure 8 is a screen shot showing the real time PCR result screen of a Flow Pro Fluidic Handling System (Global FlA, Fox Island, WA). Controls are unprocessed Yersinia pestis suspended in water at a concentration of 104 cfulml and NTC
(no template control).
This description is intended to be read in connection .with the. accompanying drawings, which are to be considered part of the entire written description of this invention. The drawing .figures are not necessarily to scale and certain features of the invention may be shown exaggerated in scale or in somewhat schematic form in the interest of clarity and conciseness. In the description, relative terms such as "front,"
"back," "up," "down," "top" and "bottom," as well as derivatives thereof, should be construed to refer to the orientation as then described or as shown in the drawing figure under discussion.. These relative terms are for convenience of description and normally are not intended to require a particular orientation. Terms concerning attachments, 2.5 coupling and the like, such as "connected" and "attached," refer to a relationship wherein structures are secured or attached to one another either directly or indirectly through intervening structures, as well as both movable or rigid attachments or relationships, unless expressly described otherwise.
In describing embodiments of the present invention, specific terminology is employed for the sake of clarity. However, the invention is not intended to be limited to the specific terminology so selected. It is to be understood that each specific element .includes all technical equivalents which operate in a. similar manner to accomplish a similar purpose.
4 One aspect of the present invention relates to a sample preparation device. In one embodiment, the sample preparation device includes a. housing that defines a sample passage way between two openings, and a filter structure embedded in a section of the passage way. The filter structure includes a monolith adsorbent that specifically binds to nucleic acids.
The term "monolith adsorbent" or "monolithic adsorbent material," as used in the embodiments described hereinafter, refers to a porous, three-dimensional adsorbent material having a continuous interconnected pore structure in a single .piece.
A monolith is prepared, for example, by casting, sintering or polymerizing precursors into a mold of a -10 desired shape. The term "monolith adsorbent " or "monolithic adsorbent material" is meant to be distinguished from a collection of individual adsorbent particles packed into a bed formation or embedded into a porous matrix, in which the end product.
comprises individual adsorbent particles. The term "monolith adsorbent " or "monolithic adsorbent material" is also meant to be distinguished from a collection of adsorbent fibers or fibers coated with an adsorbent, such as filter papers or filter papers coated with an adsorbent.
The term "specifically bind to" or "specific binding," as used in the embodiments described hereinafter, refers to the 'binding of the adsorbent to an analyte (e.g., nucleic acids) with a specificity that is sufficient to differentiate the analyte from other components or contaminants of a sample. in one embodiment, the dissociation constant of the adsorbentiligand complex" is less than about I x1.0-6 .M. A person of ordinary skill in the art understands that stringency of the binding and elution of the analyte to the.
adsorbent can be controlled by binding and elution buffer formulations. For example, elution. stringencies for nucleic acids can be controlled by salt concentrations using KCI
or 'NaCi. 'Nucleic acids, with their higher negative charge, are more resistant to elution than proteins. Temperature, pH, and mild detergent are other treatments that could be used for selective binding and elution. Thermal consistency of the binding, and elution may be maintained with a heat block or a water bath. The manipulation of the binding buffer is preferable since the impact of the modified elution buffer on the downstream analyzer would need to be evaluated.
The term "nucleic acid," as used in the embodiments described hereinafter, refers to individual nucleic acids and polymeric chains of nucleic acids, including DNA and RNA, whether .naturally occurring or artificially synthesized (including analogs thereof), or modifications .thereof, especially those modifications known to occur in nature, having any length. Examples of nucleic acid lengths that are in accord with the present invention include, without limitation, lengths suitable for PCR products (e.g., about 50 to 700 base pairs (bp)) and human genomic DNA (e.g, on an order from about kilobase pairs (Kb) to gigabase pairs (Gb)), Thus, it will be appreciated that the term "nucleic acid"
encompasses single nucleic acids as well as stretches of nucleotides, nucleosides, natural
The term "monolith adsorbent" or "monolithic adsorbent material," as used in the embodiments described hereinafter, refers to a porous, three-dimensional adsorbent material having a continuous interconnected pore structure in a single .piece.
A monolith is prepared, for example, by casting, sintering or polymerizing precursors into a mold of a -10 desired shape. The term "monolith adsorbent " or "monolithic adsorbent material" is meant to be distinguished from a collection of individual adsorbent particles packed into a bed formation or embedded into a porous matrix, in which the end product.
comprises individual adsorbent particles. The term "monolith adsorbent " or "monolithic adsorbent material" is also meant to be distinguished from a collection of adsorbent fibers or fibers coated with an adsorbent, such as filter papers or filter papers coated with an adsorbent.
The term "specifically bind to" or "specific binding," as used in the embodiments described hereinafter, refers to the 'binding of the adsorbent to an analyte (e.g., nucleic acids) with a specificity that is sufficient to differentiate the analyte from other components or contaminants of a sample. in one embodiment, the dissociation constant of the adsorbentiligand complex" is less than about I x1.0-6 .M. A person of ordinary skill in the art understands that stringency of the binding and elution of the analyte to the.
adsorbent can be controlled by binding and elution buffer formulations. For example, elution. stringencies for nucleic acids can be controlled by salt concentrations using KCI
or 'NaCi. 'Nucleic acids, with their higher negative charge, are more resistant to elution than proteins. Temperature, pH, and mild detergent are other treatments that could be used for selective binding and elution. Thermal consistency of the binding, and elution may be maintained with a heat block or a water bath. The manipulation of the binding buffer is preferable since the impact of the modified elution buffer on the downstream analyzer would need to be evaluated.
The term "nucleic acid," as used in the embodiments described hereinafter, refers to individual nucleic acids and polymeric chains of nucleic acids, including DNA and RNA, whether .naturally occurring or artificially synthesized (including analogs thereof), or modifications .thereof, especially those modifications known to occur in nature, having any length. Examples of nucleic acid lengths that are in accord with the present invention include, without limitation, lengths suitable for PCR products (e.g., about 50 to 700 base pairs (bp)) and human genomic DNA (e.g, on an order from about kilobase pairs (Kb) to gigabase pairs (Gb)), Thus, it will be appreciated that the term "nucleic acid"
encompasses single nucleic acids as well as stretches of nucleotides, nucleosides, natural
5 or artificial, and combinations thereof', in small fragments, e.g., expressed sequence tags or genetic fragments, as well as larger chains as exemplified by genomic material including individual genes and even whole chromosomes.
Referring now to Figure IA. an embodiment of the sample preparation device 100 includes a housing 10 and a sample filter 20. The housing 10 defines a sample passage way 12 between a. first opening 14 and a second opening 16. The shape and size of the housing 10 are not particularly limited.
The preferred housing configuration is substantially cylindrical so that the flow vectors during operation are substantially straight, thereby minimizing or avoiding dilutional washing that might occur with non-cylindrical configurations. In the embodiments shown in Figures 1A-1D, the housing 10 has a pipette tip geometry, i.e., the first opening 14 has a diameter that is greater than the diameter of said second opening 16, and the first opening 14 is dimensioned to fit into the tip of a pipettor. The sample filter 20 is placed in the close proximity of the second opening 16 so that samples are -filtered immediately after being taken into the housing 10 through the second opening 16, in one embodiment, the sample filter 20 is contiguous with the second opening 16. In another embodiment, the sample filter 20 is separated from the second opening 16 by a distance of 1-20 mm. In another embodiment, the housing 10 has a column geometry.
In one embodiment, the housing 10 has a volume of about 0.1 pi to about 10 In another embodiment, the housing 10 has a volume of about 5 pl to about 5 mi.
Suitable materials for the housing 10 are not particularly limited, and include plastics (such as polyethylene, polypropylene, and polystyrene), glass and stainless steel.
The sample filter 20 can be made of any porous monolithic material that binds specifically to nucleic acids. The porority of the porous monolithic material is application dependent. In general, the porous monolithic material should have a porosity that allows for a desired sample flow rate for a particular application.
In one embodiment, the sample filter 20 is made of a finely porous glass frit through which a liquid sample may pass. Porous glass frits, which are sintered glass that begins with crushing beads in a hot press to form a single monolithic structure, are excellent substrates for purifying nucleic acids. The uniform structure of the frit provides
Referring now to Figure IA. an embodiment of the sample preparation device 100 includes a housing 10 and a sample filter 20. The housing 10 defines a sample passage way 12 between a. first opening 14 and a second opening 16. The shape and size of the housing 10 are not particularly limited.
The preferred housing configuration is substantially cylindrical so that the flow vectors during operation are substantially straight, thereby minimizing or avoiding dilutional washing that might occur with non-cylindrical configurations. In the embodiments shown in Figures 1A-1D, the housing 10 has a pipette tip geometry, i.e., the first opening 14 has a diameter that is greater than the diameter of said second opening 16, and the first opening 14 is dimensioned to fit into the tip of a pipettor. The sample filter 20 is placed in the close proximity of the second opening 16 so that samples are -filtered immediately after being taken into the housing 10 through the second opening 16, in one embodiment, the sample filter 20 is contiguous with the second opening 16. In another embodiment, the sample filter 20 is separated from the second opening 16 by a distance of 1-20 mm. In another embodiment, the housing 10 has a column geometry.
In one embodiment, the housing 10 has a volume of about 0.1 pi to about 10 In another embodiment, the housing 10 has a volume of about 5 pl to about 5 mi.
Suitable materials for the housing 10 are not particularly limited, and include plastics (such as polyethylene, polypropylene, and polystyrene), glass and stainless steel.
The sample filter 20 can be made of any porous monolithic material that binds specifically to nucleic acids. The porority of the porous monolithic material is application dependent. In general, the porous monolithic material should have a porosity that allows for a desired sample flow rate for a particular application.
In one embodiment, the sample filter 20 is made of a finely porous glass frit through which a liquid sample may pass. Porous glass frits, which are sintered glass that begins with crushing beads in a hot press to form a single monolithic structure, are excellent substrates for purifying nucleic acids. The uniform structure of the frit provides
6 predictable liquid flow inside the frit and allows the eluent to have similar fluid dynamics as the sample flow. The predictable liquid flow also leads to a higher recovery during the elution process.
Exemplary glass frit pore sizes suitable for use with the present invention, including .the vatious embodiments described herein, are between about 2 microns and about 220 microns, In one embodiment, the glass frit has a pore size between about 2 microns and about 100 microns. In another embodiment, the glass fit has a pore size between about 40 microns and about 75 microns. In another embodiment, the glass frit has a pore size between about 150 microns and about 200 microns. In yet another embodiment, the glass fit has a pore size 'between about 2 microns and about 20 microns..
For applications involving purification of microbial DNA, a glass flit size of between about 10 microns and about 15 microns is suitable.
in one embodiment, the glass frit has a thickness between about 1 mm and about mm, in another embodiment, the glass frit has a thickness between about 2 mm and 15 about 5 mm. In yet another embodiment, the glass frit has a thickness between about 2 mm and about 3 mm, In another embodiment, the glass frit is chemically treated to fined onalize its surface. For example, the glass flits may be derivatized with aminosilanes or treated with the ChargeSwitch. technology (Invitrogen, Carlsbad, CA) to create positive charges for 20 better adsorption of the negatively charged nucleic acids.
While the glass frit is a good adsorbent for nucleic acids, a skilled artisan would recognize that the glass frit may also be used to absorb other types of molecules. For example, the glass frit may be coated with antibodies to extract other ligand of interest from the sample. In one embodiment, the glass frit is derivatized in 2.5 polymethylmetbaciylate (PMMA) and cyclo-olefin-copolymer COC with antibodies as capture moieties for microbes and toxin. The term "antibody', as used herein, is used in the broadest possible sense and may include but is not limited to an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibodyõ
a mon ospecific antibody, a bispecific antibody, a multispecifie antibody, a chimeric antibody, a. heteroantibody, a monoclonal antibody, a polyclonal antibody, a cameli zed antibody, a deimmunized antibody, and an anti-idiotypic antibody. The term "antibody"
.may also include but is not limited to an antibody fragment such as at least a portion of an intact antibody, for instance, the antigen binding variable region. Examples of antibody fragments include Fy, Fab, Fab', flab), F(abt)2, Fy fragment, diabody, linear antibody,
Exemplary glass frit pore sizes suitable for use with the present invention, including .the vatious embodiments described herein, are between about 2 microns and about 220 microns, In one embodiment, the glass frit has a pore size between about 2 microns and about 100 microns. In another embodiment, the glass fit has a pore size between about 40 microns and about 75 microns. In another embodiment, the glass frit has a pore size between about 150 microns and about 200 microns. In yet another embodiment, the glass fit has a pore size 'between about 2 microns and about 20 microns..
For applications involving purification of microbial DNA, a glass flit size of between about 10 microns and about 15 microns is suitable.
in one embodiment, the glass frit has a thickness between about 1 mm and about mm, in another embodiment, the glass frit has a thickness between about 2 mm and 15 about 5 mm. In yet another embodiment, the glass frit has a thickness between about 2 mm and about 3 mm, In another embodiment, the glass frit is chemically treated to fined onalize its surface. For example, the glass flits may be derivatized with aminosilanes or treated with the ChargeSwitch. technology (Invitrogen, Carlsbad, CA) to create positive charges for 20 better adsorption of the negatively charged nucleic acids.
While the glass frit is a good adsorbent for nucleic acids, a skilled artisan would recognize that the glass frit may also be used to absorb other types of molecules. For example, the glass frit may be coated with antibodies to extract other ligand of interest from the sample. In one embodiment, the glass frit is derivatized in 2.5 polymethylmetbaciylate (PMMA) and cyclo-olefin-copolymer COC with antibodies as capture moieties for microbes and toxin. The term "antibody', as used herein, is used in the broadest possible sense and may include but is not limited to an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibodyõ
a mon ospecific antibody, a bispecific antibody, a multispecifie antibody, a chimeric antibody, a. heteroantibody, a monoclonal antibody, a polyclonal antibody, a cameli zed antibody, a deimmunized antibody, and an anti-idiotypic antibody. The term "antibody"
.may also include but is not limited to an antibody fragment such as at least a portion of an intact antibody, for instance, the antigen binding variable region. Examples of antibody fragments include Fy, Fab, Fab', flab), F(abt)2, Fy fragment, diabody, linear antibody,
7 single-chain antibody molecule, multispecific antibody, and/or other antigen binding sequences of an antibody. In another embodiment, the glass frit is coated with lectins, which bind to carbohydrates found in bacteria coats and can be used to capture bacteria in a sample.
In another embodiment, the sample filter 20 is made of a porous glass monolith, a porous glass-ceramic, or porous monolithic polymers. Porous glass monolith may be produced using the sol-gel methods described in U.S. Patent Nos. 4,810,674 and 4,765,818.
Porous glass-ceramic may be produced by controlled crystallization of a porous glass monolith.
Porous monolithic polymers are a new category of materials developed during the last decade. In contrast to polymers composed of very small beads, a monolith is a single, continuous piece of a polymer prepared using a simple molding process. In one embodiment, the housing 10 serves as the mold for the porous monolithic polymers. Briefly, a section of the passage way 12 of the housing 10 is filled with a liquid mixture of monomers and porogens.
Next, a mask that is opaque to ultraviolet light is placed over the filed section. The mask has a small slit that exposes a small portion of the filled section. Finally, the monomers/porogens mixture in the filled section is irradiated with ultraviolet light through the tiny opening on the mask. The UV irradiation triggers a polymerization process that produces a solid but porous monolithic material in the filled section of the passage way 12.
In yet another embodiment, the sample filter 20 is made of a hydrophilic matrix with impregnated chemicals that lyses cell membranes, denaturing proteins, and traps nucleic acids.
In one embodiment, the hydrophilic matrix is PTA paper (Whatman, Florham Park, NJ).
Biological samples are applied to the PTA paper and cells contained in the sample are lysed on the paper. The paper is washed to remove any non-DNA material (the DNA remains entangled within the paper). The DNA is then eluted for subsequent analysis.
The sample filter 20 is shaped to fit tightly into the passage way 12 to prevent the sample from channeling or bypassing the sample filter 20 during operation.
In one embodiment, the filter 20 is fitted into the passage way 12 through mechanical means such as crimping, press fitting, and heat shrinking the housing 10 or a portion thereof In another embodiment, the filter 20 is attached to the interior of passage way 12 through an adhesive. In yet another embodiment, the side of the frit is tapered to the contour of the passage way 12. In the embodiments shown in Figures 1A-1D, the housing 10 has the
In another embodiment, the sample filter 20 is made of a porous glass monolith, a porous glass-ceramic, or porous monolithic polymers. Porous glass monolith may be produced using the sol-gel methods described in U.S. Patent Nos. 4,810,674 and 4,765,818.
Porous glass-ceramic may be produced by controlled crystallization of a porous glass monolith.
Porous monolithic polymers are a new category of materials developed during the last decade. In contrast to polymers composed of very small beads, a monolith is a single, continuous piece of a polymer prepared using a simple molding process. In one embodiment, the housing 10 serves as the mold for the porous monolithic polymers. Briefly, a section of the passage way 12 of the housing 10 is filled with a liquid mixture of monomers and porogens.
Next, a mask that is opaque to ultraviolet light is placed over the filed section. The mask has a small slit that exposes a small portion of the filled section. Finally, the monomers/porogens mixture in the filled section is irradiated with ultraviolet light through the tiny opening on the mask. The UV irradiation triggers a polymerization process that produces a solid but porous monolithic material in the filled section of the passage way 12.
In yet another embodiment, the sample filter 20 is made of a hydrophilic matrix with impregnated chemicals that lyses cell membranes, denaturing proteins, and traps nucleic acids.
In one embodiment, the hydrophilic matrix is PTA paper (Whatman, Florham Park, NJ).
Biological samples are applied to the PTA paper and cells contained in the sample are lysed on the paper. The paper is washed to remove any non-DNA material (the DNA remains entangled within the paper). The DNA is then eluted for subsequent analysis.
The sample filter 20 is shaped to fit tightly into the passage way 12 to prevent the sample from channeling or bypassing the sample filter 20 during operation.
In one embodiment, the filter 20 is fitted into the passage way 12 through mechanical means such as crimping, press fitting, and heat shrinking the housing 10 or a portion thereof In another embodiment, the filter 20 is attached to the interior of passage way 12 through an adhesive. In yet another embodiment, the side of the frit is tapered to the contour of the passage way 12. In the embodiments shown in Figures 1A-1D, the housing 10 has the
8 shape of a fiustoconical pipette tip with the first opening 14 dimensioned to fit on the end of a liquid delivery system, such as a manual pipettor or an electronic p1 petting device.
Samples are taken up though the second opening 16, passed through the sample filter 20 and then retained in the section of the housing 10 that is above the sample filter 20. In one embodiment, the liquid delivery system is an electronic Opening device, such as an electronic pipettor or a robotic Opening station.
In one embodiment, the sample filter 20 includes at least. two sections, a first.
section 22 that binds specifically to nucleic acids and a second section 24 that specifically binds to another analyte of interest, such as proteins (Figure 1B), in another embodiment, the housing 10 contains a pre-filter 30 placed between the second opening 16 and the sample filter 20 (Figure IC). The pre-filter 30 has a pore size, that is larger than the pore size of the sample filter 20 and does not bind specifically to nucleic acids.
in yet another embodiment, the housing contains an aerosol filter 40 in the proximity of the first opening.
14 to prevent contamination from the pumping device (Figure 1.1)).
s In another embodiment, the housing 10 further contains a plurality of mechanical lysing beads, such as glass beads, in the space between the sample filter 20 and the aerosol filter 40, The mechanical 1-ysing 'beads are used to disrupt the cells and release the nucleic acid by vortexing the entire sample preparation device 100. In this embodiment, the second opening 16 may be covered with a cap during vortexing to prevent the liquid from escaping from the second opening 16..
Another aspect of the present invention relates to an integrated sample preparation cartridge. Referring now to Figures 2A-2C, an embodiment 200 of the integrated sample preparation cartridge .includes a base 50 and the sample preparation device 100. The base 50 contains a first sample port 51 and a second sample port 52 on the top surface M, a 2.5 third sample port 53 and a fourth sample port 54 at the bottom surface 62, a .first channel 55 connecting the first sample port 51. to the third sample port 53, a second channel 56 connecting the second sample port 52 to the fourth sample port 54, and a.
third channel 57 connecting the first channel 55 and the second channel 56.
The first sample port 51 is configured to receive the sample preparation device 100, so that the sample preparation device 100, whether in a column configuration or pipette tip configuration, can be easily inserted into the first sample port 51 and form a liquid-tight seal with the base 50.
Once attached to the first sample port 51, the sample preparation device 100 maintains a vertical position. A sample may be loaded onto the sample preparation
Samples are taken up though the second opening 16, passed through the sample filter 20 and then retained in the section of the housing 10 that is above the sample filter 20. In one embodiment, the liquid delivery system is an electronic Opening device, such as an electronic pipettor or a robotic Opening station.
In one embodiment, the sample filter 20 includes at least. two sections, a first.
section 22 that binds specifically to nucleic acids and a second section 24 that specifically binds to another analyte of interest, such as proteins (Figure 1B), in another embodiment, the housing 10 contains a pre-filter 30 placed between the second opening 16 and the sample filter 20 (Figure IC). The pre-filter 30 has a pore size, that is larger than the pore size of the sample filter 20 and does not bind specifically to nucleic acids.
in yet another embodiment, the housing contains an aerosol filter 40 in the proximity of the first opening.
14 to prevent contamination from the pumping device (Figure 1.1)).
s In another embodiment, the housing 10 further contains a plurality of mechanical lysing beads, such as glass beads, in the space between the sample filter 20 and the aerosol filter 40, The mechanical 1-ysing 'beads are used to disrupt the cells and release the nucleic acid by vortexing the entire sample preparation device 100. In this embodiment, the second opening 16 may be covered with a cap during vortexing to prevent the liquid from escaping from the second opening 16..
Another aspect of the present invention relates to an integrated sample preparation cartridge. Referring now to Figures 2A-2C, an embodiment 200 of the integrated sample preparation cartridge .includes a base 50 and the sample preparation device 100. The base 50 contains a first sample port 51 and a second sample port 52 on the top surface M, a 2.5 third sample port 53 and a fourth sample port 54 at the bottom surface 62, a .first channel 55 connecting the first sample port 51. to the third sample port 53, a second channel 56 connecting the second sample port 52 to the fourth sample port 54, and a.
third channel 57 connecting the first channel 55 and the second channel 56.
The first sample port 51 is configured to receive the sample preparation device 100, so that the sample preparation device 100, whether in a column configuration or pipette tip configuration, can be easily inserted into the first sample port 51 and form a liquid-tight seal with the base 50.
Once attached to the first sample port 51, the sample preparation device 100 maintains a vertical position. A sample may be loaded onto the sample preparation
9 device 100 from either the first opening 14 (i.e., going down the sample passage way 12) or the second opening 16 (i.e.., going the sample passage way 12).
Alternatively, the sample preparation device 100 may be attached to the first sample port 51 with a pre loaded sample.
The second sample port 52 can also be used to introduce a liquid into the integrated sample preparation cartridge 200 or to take out a liquid from the integrated sample preparation cartridge 200. The second sample port 52 is configured to receive the tip 26 of a liquid delivering device, such as a pipettor or a. robotic pipetting. station. In one embodiment, the second sample port 52 is a self-sealing inlet containing a seal 58 that can be punctured by a pipette tip and seals after the removal of the tip. Such a self-sealing entry port for a pipette allows easy introduction of the sample without the risk of opening caps, which are often a cause of contamination. In one embodiment, the seal 58 is a MultisipTM split septum plug from Abgene (Epsom, UK). in another embodiment, the seal 58 is a port valve, such as the Duckbill valves and dome valves from Minivalve International (Yellow Springs, OH). In another embodiment, the first sample port 51 also contains a self-sealing device, such as a dome .valve or a septum, that is receptive to the sample preparation device 100, In another embodiment, either the first sample port 51 or the second sample port 52 or both ports can be sealed with a screw cap or a press fit cap to allow the introduction and removal of samples. The ports can also be sealed with a tape seal to prevent leaking during the automation process.
The first channel 55, the second channel 56 and the third channel 57 connect the -first sample port 51 to the second sample port 5.2 so that the nucleic acid purifiaction process can be completed within the integrated sample preparation cartridge 200. The 2.5 third sample port 53 and the fourth sample port 54 ina.y be connected to waste bottles to collect the flo-w-through from the sample preparation device 100.
The integrated sample preparation cartridge 200 can be configured to be compatible with fluidic control systems, such as the Flow Pro Fluidic Handling System (Global HA, Fox Island, WA. In one embodiment, the first sample outlet 53 and the second sample outlet 54 are fitted with Luer-activated valves 59. The Luer-activated valves 59 are normally closed valves that may he opened only upon insertion of a luer-type fitting. The Luer-activated valves 59 allow easy insertion into the fluidic control system and prevent leaking of sample from the sample preparation cartridge 200 after the sample preparation cartridge 200 is removed from the fluidic control system.
In one embodiment, the integrated sample preparation cartridge. 200 is designed to be plugged into a fluidic control system without the need for tightening screws or a.djusting bolts.
A person of ordinary skill in the art understands that the general layout of the integrated sample preparation cartridge 200 allows for other sample introduction and elution withdrawal strategies. In one embodiment, the sample preparation cartridge 200 is connected to a fluidic control system. The sample preparation device 100 is inserted into the first sample port Si. A sample is introduced into the integrated sample preparation cartridge 200 through the second sample port 52, which is sealed off after the introduction of the sample. A chaotropheõ such as guanidine, is introduced into the
Alternatively, the sample preparation device 100 may be attached to the first sample port 51 with a pre loaded sample.
The second sample port 52 can also be used to introduce a liquid into the integrated sample preparation cartridge 200 or to take out a liquid from the integrated sample preparation cartridge 200. The second sample port 52 is configured to receive the tip 26 of a liquid delivering device, such as a pipettor or a. robotic pipetting. station. In one embodiment, the second sample port 52 is a self-sealing inlet containing a seal 58 that can be punctured by a pipette tip and seals after the removal of the tip. Such a self-sealing entry port for a pipette allows easy introduction of the sample without the risk of opening caps, which are often a cause of contamination. In one embodiment, the seal 58 is a MultisipTM split septum plug from Abgene (Epsom, UK). in another embodiment, the seal 58 is a port valve, such as the Duckbill valves and dome valves from Minivalve International (Yellow Springs, OH). In another embodiment, the first sample port 51 also contains a self-sealing device, such as a dome .valve or a septum, that is receptive to the sample preparation device 100, In another embodiment, either the first sample port 51 or the second sample port 52 or both ports can be sealed with a screw cap or a press fit cap to allow the introduction and removal of samples. The ports can also be sealed with a tape seal to prevent leaking during the automation process.
The first channel 55, the second channel 56 and the third channel 57 connect the -first sample port 51 to the second sample port 5.2 so that the nucleic acid purifiaction process can be completed within the integrated sample preparation cartridge 200. The 2.5 third sample port 53 and the fourth sample port 54 ina.y be connected to waste bottles to collect the flo-w-through from the sample preparation device 100.
The integrated sample preparation cartridge 200 can be configured to be compatible with fluidic control systems, such as the Flow Pro Fluidic Handling System (Global HA, Fox Island, WA. In one embodiment, the first sample outlet 53 and the second sample outlet 54 are fitted with Luer-activated valves 59. The Luer-activated valves 59 are normally closed valves that may he opened only upon insertion of a luer-type fitting. The Luer-activated valves 59 allow easy insertion into the fluidic control system and prevent leaking of sample from the sample preparation cartridge 200 after the sample preparation cartridge 200 is removed from the fluidic control system.
In one embodiment, the integrated sample preparation cartridge. 200 is designed to be plugged into a fluidic control system without the need for tightening screws or a.djusting bolts.
A person of ordinary skill in the art understands that the general layout of the integrated sample preparation cartridge 200 allows for other sample introduction and elution withdrawal strategies. In one embodiment, the sample preparation cartridge 200 is connected to a fluidic control system. The sample preparation device 100 is inserted into the first sample port Si. A sample is introduced into the integrated sample preparation cartridge 200 through the second sample port 52, which is sealed off after the introduction of the sample. A chaotropheõ such as guanidine, is introduced into the
10 integrated sample preparation cartridge 200 through the fourth sample port 54 by the fluidic control system and mixed with the sample within the integrated sample preparation carnidge 200. The sample/chaotrophe mixture is then pushed into the sample.
preparation device 100 from the second opening 16 of the sample preparation device 100, passing the filter 20 and entering the section of the housing 10 that is above the sample filter 2Ø The samplelcbaotrophe mixture is then withdrawn from the integrated sample preparation cartridge 200 through the fourth sample port 54 and discarded as waste. A.
washing buffer is introduced into the integrated sample preparation cartridge 200 through the third sample port 53 by the fluidic control system. Similar to the movement of the samplelcha.otrophe mixture, the washing buffer is forced into and then withdrawn from the sample preparation device 100, passing the filter 20 twice during the process. The washing step may be repeated several -times. Finally, an eluting buffer is introduced into the sample preparation device 100 through the second opening 16, eluting the bound nucleic acids into the section of the housing 10 that is above the sample filter 20, from where the chi= is removed for further analysis.
In another embodiment, the sample is introduced through the. first opening 14 of the sample preparation device 1.00 which is attached to the first sample port 51, and the eluant is removed from the second sample port 52, In another embodiment, the sample is introduced through the first opening 14 of sample preparation device 100, which is attached to the first sample port 51, and the eluant is removed from the first opening 14 of sample preparation device 100. In another embodiment, the sample is introduced onto the.
sample preparation device 100, which is attached to the first sample port 51, through the second sample port 52, and the eluant is removed from the second sample port 52. in another embodiment, the sample is pre-loaded into the sample preparation device 100 before the sample preparation device 100 is inserted into the first sample port 51 of the
preparation device 100 from the second opening 16 of the sample preparation device 100, passing the filter 20 and entering the section of the housing 10 that is above the sample filter 2Ø The samplelcbaotrophe mixture is then withdrawn from the integrated sample preparation cartridge 200 through the fourth sample port 54 and discarded as waste. A.
washing buffer is introduced into the integrated sample preparation cartridge 200 through the third sample port 53 by the fluidic control system. Similar to the movement of the samplelcha.otrophe mixture, the washing buffer is forced into and then withdrawn from the sample preparation device 100, passing the filter 20 twice during the process. The washing step may be repeated several -times. Finally, an eluting buffer is introduced into the sample preparation device 100 through the second opening 16, eluting the bound nucleic acids into the section of the housing 10 that is above the sample filter 20, from where the chi= is removed for further analysis.
In another embodiment, the sample is introduced through the. first opening 14 of the sample preparation device 1.00 which is attached to the first sample port 51, and the eluant is removed from the second sample port 52, In another embodiment, the sample is introduced through the first opening 14 of sample preparation device 100, which is attached to the first sample port 51, and the eluant is removed from the first opening 14 of sample preparation device 100. In another embodiment, the sample is introduced onto the.
sample preparation device 100, which is attached to the first sample port 51, through the second sample port 52, and the eluant is removed from the second sample port 52. in another embodiment, the sample is pre-loaded into the sample preparation device 100 before the sample preparation device 100 is inserted into the first sample port 51 of the
11 integrated sample preparation cartridge 200. After the washing and eluting steps, the eluant is removed from the second sample port 52. In yet another embodiment, the sample is pre-loaded into the sample preparation device 100 before the sample preparation device 100 is inserted into the first sample port 51 of the integrated sample preparation cartridge 200. After .the washing step, the analyte bound on the sample filter 20 are eluted into the sample preparation device 100, which is then removed from the first sample port 51 with .the purified analyte in the elution buffer within the space between the.
sample filter 20 and the aerosol filter 40.
The integrated sample preparation cartridge 200 is easy to use. First, this device does not require centrifugation and thus eliminates the complexity associated with transferring samples .from tubes to spin COIUMTIS as well as simplifies the instrumentation required. Additionally a self-sealing entry port fbr a pipettor allows easy introduction of the sample without the risk of opening caps, Which are often a cause of contamination.
A.dditionally, the Luer-activated valves make cartridge insertion and removal simple and easy without the risk of losing sample due to leakage after the process is complete.
In addition, the vortical orientation of the sam.ple preparation device 100 forces 'bubbles to rise to the top of the device from the sample -filter 20, which improves fluidic control and enhances analyte binding and. elution, Additionally, the small pores of the sample filter 20 reduces large air boluses into small bubbles which migrate to the top of the liquid column inside the sample passage way 12, creating a vibrant mixing effect of the chaotrophe with the sample. It should be noted that the pipette tip configuration of the sample preparation device 100 allows bidirectional flow of the samplelwashinglelution liquids through the sample filter 20, while most sample preparation approaches rely on flow in only one direction through the filter, The bidirectional flow feature not only allows the sample liquid to be taken into the sample preparation device 100 and elated out of the sample preparation device 100 from the same opening (e.g., the second opening 16), but also permits a. user to pipette a sample up and down for a number of cycles, thus providing the capability to process sample volumes larger than that of the sample preparation device 100.
In one embodiment, the channels 55, 56 and 57 are designed to have the shortest.
possible length to reduce unwanted biomolecular (nucleic acid) adsorption to the interior surfaces of the integrated sample preparation cartridge 200.. The channels may also be surface coated to reduce unwanted biomolecule adsorption. in one embodiment, the
sample filter 20 and the aerosol filter 40.
The integrated sample preparation cartridge 200 is easy to use. First, this device does not require centrifugation and thus eliminates the complexity associated with transferring samples .from tubes to spin COIUMTIS as well as simplifies the instrumentation required. Additionally a self-sealing entry port fbr a pipettor allows easy introduction of the sample without the risk of opening caps, Which are often a cause of contamination.
A.dditionally, the Luer-activated valves make cartridge insertion and removal simple and easy without the risk of losing sample due to leakage after the process is complete.
In addition, the vortical orientation of the sam.ple preparation device 100 forces 'bubbles to rise to the top of the device from the sample -filter 20, which improves fluidic control and enhances analyte binding and. elution, Additionally, the small pores of the sample filter 20 reduces large air boluses into small bubbles which migrate to the top of the liquid column inside the sample passage way 12, creating a vibrant mixing effect of the chaotrophe with the sample. It should be noted that the pipette tip configuration of the sample preparation device 100 allows bidirectional flow of the samplelwashinglelution liquids through the sample filter 20, while most sample preparation approaches rely on flow in only one direction through the filter, The bidirectional flow feature not only allows the sample liquid to be taken into the sample preparation device 100 and elated out of the sample preparation device 100 from the same opening (e.g., the second opening 16), but also permits a. user to pipette a sample up and down for a number of cycles, thus providing the capability to process sample volumes larger than that of the sample preparation device 100.
In one embodiment, the channels 55, 56 and 57 are designed to have the shortest.
possible length to reduce unwanted biomolecular (nucleic acid) adsorption to the interior surfaces of the integrated sample preparation cartridge 200.. The channels may also be surface coated to reduce unwanted biomolecule adsorption. in one embodiment, the
12 channels 55, 56 and 57 have diameters in the range of 0.1-5 mm to reduce the surface-to-volume ratios and therefore reduce unwanted nucleic acid adsorption.
After the removal of the eluant, the integrated sample preparation cartridge 200 is removed from the Flow Control Station and discarded.
The base 50 of the integrated sample preparation cartridge 200 can be made of any material that is resistant to the chemicals commonly used in the sample solubilizationlwashinpielutinp process. In one embodiment, the base 50 is made of a transparent material. Examples of the base 50 materials include, but are not limited to, poiyearbonate and polypropylene.
The fluidic control system can be any fluidic control system that is capable of providing the desired flow rate in the integrated sample preparation cartridge 200 in one embodiment, the fluidic control system is the Flow Pro Fluidic Handling System by Global HA (Fox Island, WA), EXAMPLES
Example 1: Purification of nucleic acids from blood sample containing Bacillus anthracis using 2.0 ml Rainin filtered pipette tip and 3 mm glass frit In this experiment, nucleic acids were purified from a blood sample containing Bacillus anthraci.s using a 20 ml Rainin filtered pipette tip and a 3 mm glass fit (ROBU
Cilasfilter-Geraete GmbH, Germany) with the following protocol:
1. Label one 15 ml conical tube as: Flow Through, and four 1.5 ml centrifuge tubes as: Ethanol I, Ethanol 2, Ethanol 3, and Eluant 2. Mix 360 pi of blood with 40 pi of Bacillus anthracis (l0) colony forming unit (efu) ml in water) in the Flow Through tube (final concentration I 04 cfulm1).
3. Add 1120 pl of Qiagen AL Lysis Buffer to the mixture.
4. Add 80 pl of Proteinase K. (20mgitni), 5. Add 400 pl of lysozyme, vortex and spin down.
6. Incubate the sample mixture at 55 C for 1 hour.
7. Add 2000 pl of 96-100% ethanol to the Flow Through Tube. Vortex and pulse spin down the mixture.
8. Aliquot 100 pi of elution buffer (10 milt,1 Tris, pH 8.0) into the SEluant tube.
Place the tube on the heat block set at 70 C. (Elution buffer must be heated at 70'C for at least 5 minutes. Keep the buffer on the heat block until step 13.) 9. Aliquot 1 ml of 70% Ethanol into each of the three Ethanol tubes,
After the removal of the eluant, the integrated sample preparation cartridge 200 is removed from the Flow Control Station and discarded.
The base 50 of the integrated sample preparation cartridge 200 can be made of any material that is resistant to the chemicals commonly used in the sample solubilizationlwashinpielutinp process. In one embodiment, the base 50 is made of a transparent material. Examples of the base 50 materials include, but are not limited to, poiyearbonate and polypropylene.
The fluidic control system can be any fluidic control system that is capable of providing the desired flow rate in the integrated sample preparation cartridge 200 in one embodiment, the fluidic control system is the Flow Pro Fluidic Handling System by Global HA (Fox Island, WA), EXAMPLES
Example 1: Purification of nucleic acids from blood sample containing Bacillus anthracis using 2.0 ml Rainin filtered pipette tip and 3 mm glass frit In this experiment, nucleic acids were purified from a blood sample containing Bacillus anthraci.s using a 20 ml Rainin filtered pipette tip and a 3 mm glass fit (ROBU
Cilasfilter-Geraete GmbH, Germany) with the following protocol:
1. Label one 15 ml conical tube as: Flow Through, and four 1.5 ml centrifuge tubes as: Ethanol I, Ethanol 2, Ethanol 3, and Eluant 2. Mix 360 pi of blood with 40 pi of Bacillus anthracis (l0) colony forming unit (efu) ml in water) in the Flow Through tube (final concentration I 04 cfulm1).
3. Add 1120 pl of Qiagen AL Lysis Buffer to the mixture.
4. Add 80 pl of Proteinase K. (20mgitni), 5. Add 400 pl of lysozyme, vortex and spin down.
6. Incubate the sample mixture at 55 C for 1 hour.
7. Add 2000 pl of 96-100% ethanol to the Flow Through Tube. Vortex and pulse spin down the mixture.
8. Aliquot 100 pi of elution buffer (10 milt,1 Tris, pH 8.0) into the SEluant tube.
Place the tube on the heat block set at 70 C. (Elution buffer must be heated at 70'C for at least 5 minutes. Keep the buffer on the heat block until step 13.) 9. Aliquot 1 ml of 70% Ethanol into each of the three Ethanol tubes,
13 10. Pipette sample mixture into the How Through tube using frit tip (medium porosity) with a Rainin Electronic Pipettor. Pipette for 5 cycles (cycle ¨
aspirate dispense).
11. Wash the bound nucleic acids by pipetting the 70% Et0H in Ethanol 1 tube for 10 cycles using a Rainin electronic Pipettor. Repeat the wash with the 70% Et0H in Ethanol 2 tube and Ethanol 3 tube (three washes total).
12. Purge the Et01-1 from the fit tip by pipetting air for 20 cycles. Wipe the outside of the tip and tap the tip gently if a noticeable amount of ethanol is left.
13. Elute the nucleic acids on the frit by pipetting the 70 C elution buffer of step 8 for 10 cycles. The buffer may start to bubble but continue pipetting and spin down the microcentrifuge tube once complete. Make sure all the buffer has been purged from the tip.
aspirate dispense).
11. Wash the bound nucleic acids by pipetting the 70% Et0H in Ethanol 1 tube for 10 cycles using a Rainin electronic Pipettor. Repeat the wash with the 70% Et0H in Ethanol 2 tube and Ethanol 3 tube (three washes total).
12. Purge the Et01-1 from the fit tip by pipetting air for 20 cycles. Wipe the outside of the tip and tap the tip gently if a noticeable amount of ethanol is left.
13. Elute the nucleic acids on the frit by pipetting the 70 C elution buffer of step 8 for 10 cycles. The buffer may start to bubble but continue pipetting and spin down the microcentrifuge tube once complete. Make sure all the buffer has been purged from the tip.
14. Collect the eluant and discard the frit tip
15. Quantitating the eluted nucleic acids with real time IPCR.
As shown in Figure 3, nucleic acids from ftacithis anthracis are detected in the eluant.
Example 2: Purification of nucleic acids from Streptococcus pyogenes using 2.0 nil Rainin filtered pipette tip and 2 mm glass frit.
In this experiment, nucleic acids were purified from Sirepiococcus. pyogenes suspensions of various concentrations using a 2.0 ml Rainin filtered pipette tip and a 2 mm glass frit (ROBU Glasfilter-Geraete GmbH, Germany) with the following protocol:
1. Label three 1.5 ml centrifuge tubes as: Sample 4- Guanidine, Ethanol, and Eluant.
2. Lyse by vortexing with glass beads.
3. Mix 500 IA of Streptococcus pyogenes sample with 500 IA of 6M guanidine, pH
6.5, by vortexing.
An aliquot of unprocessed (i.e., the pre-guanidine) Sweptococcus pyogenes were also saved as a control for real-time PCR analysis in step 10.
4. Aliquot 100 ul elution buffer (I mM NaOH) into the eluant tube. Pipette the sample/guanidine mixture with a frit tip (medium porosity) and a Rainin Electronic Pipettor, Pipette for 5 cycles (cycle - aspirate + dispense).
5. Pipette 1 ml 70% Et0E1 to wash bound nucleic acids using the Rainin electronic Pipettor for 5 cycles.
6. Pass air through the frit tip to purge Et0H using the electronic pipettor.
Repeat pipetting for 20 cycles to remove traces of Et0H. Tap the frit tip gently if a noticeable amount of ethanol is left. Remove the Et0H on the outside of the tip with Kiln Wiper&
7. Elute the nucleic acids from the fit with the 70"C elution buffer from step 4 by pipetting for 10 cycles. Make sure all the elution buffer has been purged from the 8. Collect the du= and discard the fit tip 9. Quantitating the eluted nucleic acids with real time PCR.
As shown in :Figure 4õS'ireptococcus pyogenes nucleic adds are detected in samples prepared by the frit tip.
Example 3: Purification of nucleic acids from nasopharyngeal sample containing Bacillus anthracis using 2.0 ml Rainin filtered pipette tip and 2 mm glass frit.
in this experiment, nucleic acids were purified from nasopliaryngeal sample containing Bacillus ainhcaeis using a 2.0 ml Rainin filtered pipette tip and a 2 mm frit (ROBU (ilasfilter-Geraete GmbH, Germany) with the following protocol:
1. Label three 1.5 ml centrifuge tubes as: Sample + Guanidine, Ethanol, and :Ellawn.
2. Prepare nasophatyngeal sample by mixing 450 pi of nasopharyngeal with 50 pi of Bacillus anthracis (105 colony forming unit (cfu) ml in water) in the Sample +
Guanidine tube (final concentration 10 cfulm1), Save an aliquot of the nasopharyngeal sample as control in the real-time PCR analysis of Step 11.
3. Add 500 pi of 6i).4 guanidine, pH 6.5, into the Sample -3, Guanidine tube and vortex.
4. Aliquot 100 pl of elution buffer (10 RIM iris, pH 8.0) into the :Eluant tube. Place the tube on the heat block set at 70 C (elution buffer must heat at 70 C for at least 5 minutes). Keep the tube on the heat block until step 9, 5, Pipette the sample/guanidine mixture using a frit tip (medium porosity) with a Rainin Electronic Pi pettor, Pipette for 5 cycles (cycle ¨ aspirate +
dispense.).
6. Pipette 1 ml 70% Et0H to wash bound nucleic acids using the Rainin electronic Pipettor.
7, Pass air through the frit tip to purge Et0H using the electronic pipettor.
Repeat pipetting for 20 cycles to remove traces of Et011: Tap the -frit tip gently if a noticeable amount of ethanol is left. Remove the Et0H on the outside of the tip with Kimwipe 8. Elute the nucleic acids from the fit with the 70 C elution buffer from step 4 by pipetting for i 0 cycles. Make sure all the elution buffer has been purged from the 9. Collect the eluant and discard the frit tip 5 10. Quantitating the eluted nucleic acids with real time PCR.
As shown in Figure 5, nucleic acids from Bacillus anthracis are detected in the eluant.
:Example 4: Purification of nucleic acids front Blood sample containing Venezuela Equine Encephalitis virus using 1.2 ml Gilson filtered pipette tip and 5 mm glass frit 10 in this experiment, nucleic acids were purified from blood sample containing Venezuela Equine Encephalitis virus using a. 2.0 ml Rainin filtered pipette tip and a 5 mm glass frit (ROBU Glasfilter-Geraete GmbH, Germany) with the following protocol:
1 , Label six 1.5 ml centrifuge tubes as: Flow Through, Ethanol 1, Ethanol 2, Ethanol 3,1Eluant 1 and Eluant 2.
15 2. Mix 90 ml of blood with 10 pi of Venezuela Equine Encephalitis virus (105 plaque forming unit (pfu) / nil in water) in the Flow Through tube (final concentration 10'1 pful.m1), 3.. Add. 280 !Al of Qiagen AL Lysis Buffer to the mixture.
4. Add 40 pl of Proteinase K (20mg/m1).
5. Add 100 pi of lysozyme, vortex and spin down.
6. Incubate the sample mixture at 55 C for 1 hour.
7. Add 500 p1 of 96-100% ethanol to the Flow Through Tube. Vortex and pulse spin down the mixture.
S. Aliquot 100 pi of elution buffer (10 mA1 Tris, pH 8.0) into the :Eluant tubes. Place the tubes on the heat block set at 70 C. (Elution buffer must be heated at 70 C for at least 5 minutes. Keep the tubes on the heat block until step 13.) 9, Aliquot 1 ml of 70% Ethanol into each of the three Ethanol tubes.
10. Pipette sample mixture into the :Flow Through tube using frit tip (medium porosity) with a Gilson Electronic Pipettor. Pipette for 5 cycles (cycle aspirate + dispense). Wash the bound nucleic acids by pipetting the 70% DOH in Ethanol 1 tube for 10 cycles using the electronic :Pipettor. Repeat the wash with the 70%
F.t011 in Ethanol 2 tube and :Ethanol 3 tube (three washes total) Purge the EIGH
from the fit tip by -pipetting air for 20 cycles. Wipe the outside of the tip and tap the tip gently if a noticeable amount of ethanol is left.
As shown in Figure 3, nucleic acids from ftacithis anthracis are detected in the eluant.
Example 2: Purification of nucleic acids from Streptococcus pyogenes using 2.0 nil Rainin filtered pipette tip and 2 mm glass frit.
In this experiment, nucleic acids were purified from Sirepiococcus. pyogenes suspensions of various concentrations using a 2.0 ml Rainin filtered pipette tip and a 2 mm glass frit (ROBU Glasfilter-Geraete GmbH, Germany) with the following protocol:
1. Label three 1.5 ml centrifuge tubes as: Sample 4- Guanidine, Ethanol, and Eluant.
2. Lyse by vortexing with glass beads.
3. Mix 500 IA of Streptococcus pyogenes sample with 500 IA of 6M guanidine, pH
6.5, by vortexing.
An aliquot of unprocessed (i.e., the pre-guanidine) Sweptococcus pyogenes were also saved as a control for real-time PCR analysis in step 10.
4. Aliquot 100 ul elution buffer (I mM NaOH) into the eluant tube. Pipette the sample/guanidine mixture with a frit tip (medium porosity) and a Rainin Electronic Pipettor, Pipette for 5 cycles (cycle - aspirate + dispense).
5. Pipette 1 ml 70% Et0E1 to wash bound nucleic acids using the Rainin electronic Pipettor for 5 cycles.
6. Pass air through the frit tip to purge Et0H using the electronic pipettor.
Repeat pipetting for 20 cycles to remove traces of Et0H. Tap the frit tip gently if a noticeable amount of ethanol is left. Remove the Et0H on the outside of the tip with Kiln Wiper&
7. Elute the nucleic acids from the fit with the 70"C elution buffer from step 4 by pipetting for 10 cycles. Make sure all the elution buffer has been purged from the 8. Collect the du= and discard the fit tip 9. Quantitating the eluted nucleic acids with real time PCR.
As shown in :Figure 4õS'ireptococcus pyogenes nucleic adds are detected in samples prepared by the frit tip.
Example 3: Purification of nucleic acids from nasopharyngeal sample containing Bacillus anthracis using 2.0 ml Rainin filtered pipette tip and 2 mm glass frit.
in this experiment, nucleic acids were purified from nasopliaryngeal sample containing Bacillus ainhcaeis using a 2.0 ml Rainin filtered pipette tip and a 2 mm frit (ROBU (ilasfilter-Geraete GmbH, Germany) with the following protocol:
1. Label three 1.5 ml centrifuge tubes as: Sample + Guanidine, Ethanol, and :Ellawn.
2. Prepare nasophatyngeal sample by mixing 450 pi of nasopharyngeal with 50 pi of Bacillus anthracis (105 colony forming unit (cfu) ml in water) in the Sample +
Guanidine tube (final concentration 10 cfulm1), Save an aliquot of the nasopharyngeal sample as control in the real-time PCR analysis of Step 11.
3. Add 500 pi of 6i).4 guanidine, pH 6.5, into the Sample -3, Guanidine tube and vortex.
4. Aliquot 100 pl of elution buffer (10 RIM iris, pH 8.0) into the :Eluant tube. Place the tube on the heat block set at 70 C (elution buffer must heat at 70 C for at least 5 minutes). Keep the tube on the heat block until step 9, 5, Pipette the sample/guanidine mixture using a frit tip (medium porosity) with a Rainin Electronic Pi pettor, Pipette for 5 cycles (cycle ¨ aspirate +
dispense.).
6. Pipette 1 ml 70% Et0H to wash bound nucleic acids using the Rainin electronic Pipettor.
7, Pass air through the frit tip to purge Et0H using the electronic pipettor.
Repeat pipetting for 20 cycles to remove traces of Et011: Tap the -frit tip gently if a noticeable amount of ethanol is left. Remove the Et0H on the outside of the tip with Kimwipe 8. Elute the nucleic acids from the fit with the 70 C elution buffer from step 4 by pipetting for i 0 cycles. Make sure all the elution buffer has been purged from the 9. Collect the eluant and discard the frit tip 5 10. Quantitating the eluted nucleic acids with real time PCR.
As shown in Figure 5, nucleic acids from Bacillus anthracis are detected in the eluant.
:Example 4: Purification of nucleic acids front Blood sample containing Venezuela Equine Encephalitis virus using 1.2 ml Gilson filtered pipette tip and 5 mm glass frit 10 in this experiment, nucleic acids were purified from blood sample containing Venezuela Equine Encephalitis virus using a. 2.0 ml Rainin filtered pipette tip and a 5 mm glass frit (ROBU Glasfilter-Geraete GmbH, Germany) with the following protocol:
1 , Label six 1.5 ml centrifuge tubes as: Flow Through, Ethanol 1, Ethanol 2, Ethanol 3,1Eluant 1 and Eluant 2.
15 2. Mix 90 ml of blood with 10 pi of Venezuela Equine Encephalitis virus (105 plaque forming unit (pfu) / nil in water) in the Flow Through tube (final concentration 10'1 pful.m1), 3.. Add. 280 !Al of Qiagen AL Lysis Buffer to the mixture.
4. Add 40 pl of Proteinase K (20mg/m1).
5. Add 100 pi of lysozyme, vortex and spin down.
6. Incubate the sample mixture at 55 C for 1 hour.
7. Add 500 p1 of 96-100% ethanol to the Flow Through Tube. Vortex and pulse spin down the mixture.
S. Aliquot 100 pi of elution buffer (10 mA1 Tris, pH 8.0) into the :Eluant tubes. Place the tubes on the heat block set at 70 C. (Elution buffer must be heated at 70 C for at least 5 minutes. Keep the tubes on the heat block until step 13.) 9, Aliquot 1 ml of 70% Ethanol into each of the three Ethanol tubes.
10. Pipette sample mixture into the :Flow Through tube using frit tip (medium porosity) with a Gilson Electronic Pipettor. Pipette for 5 cycles (cycle aspirate + dispense). Wash the bound nucleic acids by pipetting the 70% DOH in Ethanol 1 tube for 10 cycles using the electronic :Pipettor. Repeat the wash with the 70%
F.t011 in Ethanol 2 tube and :Ethanol 3 tube (three washes total) Purge the EIGH
from the fit tip by -pipetting air for 20 cycles. Wipe the outside of the tip and tap the tip gently if a noticeable amount of ethanol is left.
16 11. Elute the nucleic acids on the fit by pi petting the 70"C elution butler of step 8 for cycles. Remove the elution buffer from the heat block once the cycles are completed. Make sure all the buffer has been purged from the tip, 12. Collect the eluant in Eluant 1 tube, 5 13. Repeat the step 13 with the same fit tip, collect the eluant in Eluant 2 tube, and discard the frit tip 14 Quantitating the eluted nucleic acids with real time PCR
As shown in Figure 6, nucleic acids from Venezuela Equine Encephalitis virus are detected in both the -First and second eluant. The first eluant, however, contains nucleic 10 acids of Venezuela Equine Encephalitis at a much higher concentration.
Example 5: Automatic sample preparation using fluidic control system and the integrated sample preparation system A prototype of the integrated sample preparation device shown in Figure 2A was connected to a Flow Pro Fluidic Handling System (Global HA, Fox Island, WA) Nucleic acids were purified from Yersinia pe,slis suspension with the following protocol:
1, Label two 1.5 ml centrifuge tubes as: Sample and Eluant, 2, Aliquot 150 pi of 1 niM NaOH into a tube designated "Elution Buffer which is located on the Global FltA system.
3. Aliquot 500 ul 70% Et0F1 into a Wash tube which is located on the Global HA
system.
4. Mix the 500 p1 of Yersinia pestis- suspension (104c:rutin! in water) with 500 p I of 6M guanidine. pH 6.5, in the "sample" tube (step 1) and vortex. Save some un-mixed sample for analysis later.
5. Pipette the sample/guanidine mixture into frit tip (medium porosity) with a Rainirl Electronic Pipettor.
6, Place the frit tip (with sample inside) onto the Sample Prep Cartridge located on the Global FR device, 7. Perform the "Frit Tip Sample Toggle" sequence (Figure 7) using the FlotV
Software, 8. Perform the "Frit Tip Et0H Wash" sequence using the El OLV
Software.
9. Perform the "Frit Tip Et0H Dry" sequence using the FloIN Software, 10. Perform the "Frit Tip Elution" sequence using the FloLV Software.
=
As shown in Figure 6, nucleic acids from Venezuela Equine Encephalitis virus are detected in both the -First and second eluant. The first eluant, however, contains nucleic 10 acids of Venezuela Equine Encephalitis at a much higher concentration.
Example 5: Automatic sample preparation using fluidic control system and the integrated sample preparation system A prototype of the integrated sample preparation device shown in Figure 2A was connected to a Flow Pro Fluidic Handling System (Global HA, Fox Island, WA) Nucleic acids were purified from Yersinia pe,slis suspension with the following protocol:
1, Label two 1.5 ml centrifuge tubes as: Sample and Eluant, 2, Aliquot 150 pi of 1 niM NaOH into a tube designated "Elution Buffer which is located on the Global FltA system.
3. Aliquot 500 ul 70% Et0F1 into a Wash tube which is located on the Global HA
system.
4. Mix the 500 p1 of Yersinia pestis- suspension (104c:rutin! in water) with 500 p I of 6M guanidine. pH 6.5, in the "sample" tube (step 1) and vortex. Save some un-mixed sample for analysis later.
5. Pipette the sample/guanidine mixture into frit tip (medium porosity) with a Rainirl Electronic Pipettor.
6, Place the frit tip (with sample inside) onto the Sample Prep Cartridge located on the Global FR device, 7. Perform the "Frit Tip Sample Toggle" sequence (Figure 7) using the FlotV
Software, 8. Perform the "Frit Tip Et0H Wash" sequence using the El OLV
Software.
9. Perform the "Frit Tip Et0H Dry" sequence using the FloIN Software, 10. Perform the "Frit Tip Elution" sequence using the FloLV Software.
=
17 11. Once the sequence is completed, remove the frit tip from the Global FIA
system, attach the frit tip to a Rainin Electronic Pipettor and dispense the eluant into the 1.5 ml centrifuge tube labeled "Eluant".
12. Discard the frit tip 13. Quantitating the eluted nucleic acids with real time PCR.
As shown in Figure 8, nucleic acids from Yersinia pestis are detected in the eluant.
The terms and descriptions used herein are set forth by way of illustration only and are not meant as limitations. Those skilled in the art will recognize that many variations are possible.
system, attach the frit tip to a Rainin Electronic Pipettor and dispense the eluant into the 1.5 ml centrifuge tube labeled "Eluant".
12. Discard the frit tip 13. Quantitating the eluted nucleic acids with real time PCR.
As shown in Figure 8, nucleic acids from Yersinia pestis are detected in the eluant.
The terms and descriptions used herein are set forth by way of illustration only and are not meant as limitations. Those skilled in the art will recognize that many variations are possible.
Claims (27)
1. A sample preparation device comprising:
a housing defining a passage way between a first opening and a second opening;
and a sample filter occupying a section of said passage way, said sample filter comprising a monolithic adsorbent in the form of a sintered glass frit that specifically binds to nucleic acids, wherein said glass frit is not modified with a material with nucleic acid affinity.
a housing defining a passage way between a first opening and a second opening;
and a sample filter occupying a section of said passage way, said sample filter comprising a monolithic adsorbent in the form of a sintered glass frit that specifically binds to nucleic acids, wherein said glass frit is not modified with a material with nucleic acid affinity.
2. The sample preparation device of claim 1, wherein said sample filter is chemically treated to create positive charges.
3. The sample preparation device of claim 1 or 2, wherein said sample filter comprises a first section that binds specifically to nucleic acids and a second section that binds specifically to an analyte of interest.
4. The sample preparation device of any one of claims 1 to 3, wherein said first opening has a diameter that is greater than the diameter of said second opening, and wherein said sample filter is placed in the close proximity of said second opening.
5. The sample preparation device of claim 4, wherein the side of said sintered glass frit is tapered to the contour of said passage way.
6. The sample preparation device of any one of claims 1 to 5, wherein said housing further comprises a second sample filler placed in the close proximity of said sample filter.
7. The sample preparation device of any one of claims 1 to 6, wherein said housing further comprises an aerosol filter placed in the proximity of said first opening.
8. The sample preparation device of any one of claims 1 to 7, wherein said housing is in the configuration of a pipette tip.
9. An integrated sample preparation cartridge, comprising:
a sample preparation device comprising:
a housing defining a passage way between a first opening and a second opening; and a sample filter occupying a section of the passage way, said sample filter comprising a monolithic adsorbent in the form of a sintered glass frit that specifically binds to nucleic acids and is not modified with a material with nucleic acid;
and a cartridge base comprising:
a first port configured to interface with the sample preparation device;
a second port configured to interface with a liquid delivery device; and a first channel connecting said first port to said second port.
a sample preparation device comprising:
a housing defining a passage way between a first opening and a second opening; and a sample filter occupying a section of the passage way, said sample filter comprising a monolithic adsorbent in the form of a sintered glass frit that specifically binds to nucleic acids and is not modified with a material with nucleic acid;
and a cartridge base comprising:
a first port configured to interface with the sample preparation device;
a second port configured to interface with a liquid delivery device; and a first channel connecting said first port to said second port.
10. The integrated sample preparation cartridge of claim 9, wherein said cartridge base is made of a material selected from the group consisting of polycarbonate, polystyrene and polypropylene.
11. The integrated sample preparation cartridge of claim 9 or 10, wherein said liquid delivery device is a flow control station.
12. The integrated sample preparation cartridge of any one of claims 9 to 11, wherein said second port comprises a Luer-activated valve.
13. The integrated sample preparation cartridge of any one of claims 9 to 12, wherein said cartridge base further comprises:
a third port; and a second channel connecting said third port to said first port.
a third port; and a second channel connecting said third port to said first port.
14. The integrated sample preparation cartridge of claim 13, wherein said third port is a self-sealing port.
15. The integrated sample preparation cartridge of claim 13, wherein said third port comprises a septum or a one-way valve.
16. A method for purifying nucleic acids from a liquid sample, comprising:
placing said liquid sample in a container;
withdrawing at least a portion of said liquid sample into a sample preparation device comprising:
a housing defining a passage way between a first opening and a second opening; and a filter occupying a section of said passage way, said sample filter comprising a monolithic adsorbent in the form of a sintered glass frit that specifically binds to nucleic acids and is not modified with a material with nucleic acid affinity, wherein said portion of liquid sample is drawn into said housing via the first opening and passing through said filter, and wherein nucleic acids in said sample binds to said filter while passing through said filter;
expelling said portion of liquid sample from said sample preparation device via the first opening, wherein said portion of liquid sample passes through said litter a second time while exiting said sample preparation device; and eluting nucleic acids from said filter by withdrawing an eluting buffer into said sample preparation device via the first opening and expelling said eluting buffer from said sample preparation device via the first opening, wherein said eluting butter passes through said filter while entering and exiting said sample preparation device.
placing said liquid sample in a container;
withdrawing at least a portion of said liquid sample into a sample preparation device comprising:
a housing defining a passage way between a first opening and a second opening; and a filter occupying a section of said passage way, said sample filter comprising a monolithic adsorbent in the form of a sintered glass frit that specifically binds to nucleic acids and is not modified with a material with nucleic acid affinity, wherein said portion of liquid sample is drawn into said housing via the first opening and passing through said filter, and wherein nucleic acids in said sample binds to said filter while passing through said filter;
expelling said portion of liquid sample from said sample preparation device via the first opening, wherein said portion of liquid sample passes through said litter a second time while exiting said sample preparation device; and eluting nucleic acids from said filter by withdrawing an eluting buffer into said sample preparation device via the first opening and expelling said eluting buffer from said sample preparation device via the first opening, wherein said eluting butter passes through said filter while entering and exiting said sample preparation device.
17. The method of claim 16, further comprising:
washing said filter by withdrawing a washing buffer into said sample preparation device via the first opening and expelling said washing buffer from said sample preparation device via the first opening, wherein said washing buffer passes through said filter while entering and exiting said sample preparation device.
washing said filter by withdrawing a washing buffer into said sample preparation device via the first opening and expelling said washing buffer from said sample preparation device via the first opening, wherein said washing buffer passes through said filter while entering and exiting said sample preparation device.
18. The method of claim 17, wherein said washing step is repeated two or more times.
19. The method of any one of claims 16 to 18, wherein said sample withdrawing and sample expelling steps are repeated until all said liquid sample passes through said filter at least once.
20. The method of any one of claims 16 to 19, wherein said sample preparation device has the configuration of a pipette tip.
21. The method of any one of claims 16 to 20, wherein said withdrawing, expelling and eluting steps are controlled by an electronic pipettor.
22. The method of any one of claims 16 to 20, wherein said withdrawing, expelling and eluting steps are controlled by a robotic pipetting station.
23. A method for purifying nucleic acids from a sample, comprising:
passing said sample through a sample preparation device comprising:
a housing defining a passage way between a first opening and a second opening; and a filter occupying a section of said passage way, wherein said sample filter comprising a monolithic adsorbent in the form of a sintered glass frit that specifically binds to nucleic acids and is not modified with a material with nucleic acid affinity, and said sample passes through said sample filter while passing through said sample preparation device; and eluting nucleic acids bound to said sample filter with an eluting solution, wherein said sample and said eluting solution enter and exit said housing through the same opening.
passing said sample through a sample preparation device comprising:
a housing defining a passage way between a first opening and a second opening; and a filter occupying a section of said passage way, wherein said sample filter comprising a monolithic adsorbent in the form of a sintered glass frit that specifically binds to nucleic acids and is not modified with a material with nucleic acid affinity, and said sample passes through said sample filter while passing through said sample preparation device; and eluting nucleic acids bound to said sample filter with an eluting solution, wherein said sample and said eluting solution enter and exit said housing through the same opening.
24. The method of claim 23, wherein said sample preparation device is attached to a cartridge base comprising a first port configured to receive said sample preparation device and a second port configured to receive a liquid delivery device.
25. The method of claim 23 or 24, further comprising:
washing said filter with a washing solution, wherein said washing solution enter and exit said housing through the same opening.
washing said filter with a washing solution, wherein said washing solution enter and exit said housing through the same opening.
26. A sample purification system, comprising:
a sample preparation device comprising:
a housing defining a passage way between a first opening and a second opening; and a sample filter occupying a section of said passage way, said sample filter comprising a monolithic adsorbent in the form of a sintered glass frit that specifically binds to nucleic acids and is not modified with a material with nucleic acid affinity; a cartridge base comprising:
a first port configured to receive said sample preparation device;
a second port configured to receive a liquid delivery device;
a channel connecting said first sample port with said second sample port; and a liquid delivery device, connected to said cartridge base, that controls fluid flow in said sample preparation device and said cartridge base.
a sample preparation device comprising:
a housing defining a passage way between a first opening and a second opening; and a sample filter occupying a section of said passage way, said sample filter comprising a monolithic adsorbent in the form of a sintered glass frit that specifically binds to nucleic acids and is not modified with a material with nucleic acid affinity; a cartridge base comprising:
a first port configured to receive said sample preparation device;
a second port configured to receive a liquid delivery device;
a channel connecting said first sample port with said second sample port; and a liquid delivery device, connected to said cartridge base, that controls fluid flow in said sample preparation device and said cartridge base.
27. The sample purification system of claim 26, wherein said liquid delivery device delivers liquids into and removes liquids from said sample preparation device through the same opening on said housing.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/933,113 US7759112B2 (en) | 2007-10-31 | 2007-10-31 | Apparatus, system, and method for purifying nucleic acids |
| US11/933,113 | 2007-10-31 | ||
| PCT/US2008/068159 WO2009058432A1 (en) | 2007-10-31 | 2008-06-25 | Sample preparation device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2704771A1 CA2704771A1 (en) | 2009-05-07 |
| CA2704771C true CA2704771C (en) | 2017-12-12 |
Family
ID=40581474
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2703950A Expired - Fee Related CA2703950C (en) | 2007-10-31 | 2008-03-11 | Apparatus, system, and method for purifying nucleic acids |
| CA2704771A Active CA2704771C (en) | 2007-10-31 | 2008-06-25 | Sample preparation device |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2703950A Expired - Fee Related CA2703950C (en) | 2007-10-31 | 2008-03-11 | Apparatus, system, and method for purifying nucleic acids |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US7759112B2 (en) |
| EP (2) | EP2215103B1 (en) |
| JP (2) | JP5977921B2 (en) |
| CN (2) | CN101883776B (en) |
| CA (2) | CA2703950C (en) |
| HK (1) | HK1150166A1 (en) |
| WO (2) | WO2009058414A1 (en) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070017870A1 (en) * | 2003-09-30 | 2007-01-25 | Belov Yuri P | Multicapillary device for sample preparation |
| US10125388B2 (en) | 2007-10-31 | 2018-11-13 | Akonni Biosystems, Inc. | Integrated sample processing system |
| US7759112B2 (en) | 2007-10-31 | 2010-07-20 | Akonni Biosystems, Inc. | Apparatus, system, and method for purifying nucleic acids |
| US20090111193A1 (en) | 2007-10-31 | 2009-04-30 | Cooney Christopher G | Sample preparation device |
| US10300482B2 (en) | 2010-12-09 | 2019-05-28 | Akonni Biosystems, Inc. | Sample analysis system |
| US9428746B2 (en) | 2007-10-31 | 2016-08-30 | Akonni Biosystems, Inc. | Method and kit for purifying nucleic acids |
| CA2719787C (en) * | 2008-03-28 | 2017-03-07 | Biotix Inc. | Sample preparation devices and methods for processing analytes |
| WO2009121034A2 (en) * | 2008-03-28 | 2009-10-01 | Pelican Group Holdings, Inc. | Multicapillary sample preparation devices and methods for processing analytes |
| US8846878B1 (en) | 2009-01-23 | 2014-09-30 | Cubrc Corporation | Method and device for isolating a protein sample |
| CA2811888A1 (en) | 2009-09-21 | 2011-03-24 | Akonni Biosystems | Integrated cartridge |
| WO2011158815A1 (en) * | 2010-06-18 | 2011-12-22 | 東洋紡績株式会社 | Method for simultaneous achievement of bacteriolysis of acid-fast bacterium and separation of nucleic acid from the bacterium |
| GB201104206D0 (en) | 2011-03-14 | 2011-04-27 | Ge Healthcare Uk Ltd | Biological sample holder and method of assembling same |
| WO2013004366A1 (en) | 2011-07-01 | 2013-01-10 | Qiagen Gmbh | Filter module in biomolecule isolation |
| US20130017545A1 (en) * | 2011-07-11 | 2013-01-17 | Agilent Technologies, Inc. | Apparatus and methods for acquiring analytes from a dried biological fluid sample |
| US9399986B2 (en) | 2012-07-31 | 2016-07-26 | General Electric Company | Devices and systems for isolating biomolecules and associated methods thereof |
| WO2014035986A1 (en) * | 2012-08-28 | 2014-03-06 | Akonni Biosystems Inc. | Method and kit for purifying nucleic acids |
| WO2014108882A1 (en) * | 2013-01-14 | 2014-07-17 | Sabio Innovative Solutions Pvt Ltd | Separation device, filtration device therefrom, and methods therefor |
| MX2015009264A (en) | 2013-01-18 | 2016-03-31 | Biomeme Inc | Analytic device. |
| JP6628954B2 (en) * | 2013-08-30 | 2020-01-15 | 学校法人東京理科大学 | Glass filter and cancer cell separation method |
| EP3063524B1 (en) * | 2013-11-01 | 2020-02-19 | Biomeme, Inc. | Sample extraction and preparation device |
| JP6229471B2 (en) * | 2013-12-13 | 2017-11-15 | 東ソー株式会社 | Column for liquid chromatography having a convex filter |
| WO2015195949A2 (en) | 2014-06-18 | 2015-12-23 | Clear Gene, Inc. | Methods, compositions, and devices for rapid analysis of biological markers |
| CN106660048B (en) | 2014-06-19 | 2019-07-05 | 阿科尼生物系统公司 | Analysis of molecules system and its application |
| US11401558B2 (en) | 2015-12-18 | 2022-08-02 | Clear Gene, Inc. | Methods, compositions, kits and devices for rapid analysis of biological markers |
| CN107130470A (en) * | 2016-02-29 | 2017-09-05 | 新材料与产业技术北京研究院 | A kind of composite filtering film and its preparation method and application |
| EP3353525B1 (en) | 2016-02-29 | 2020-04-01 | Hewlett-Packard Development Company, L.P. | Enzymatic sample purification |
| US11161107B2 (en) | 2016-05-25 | 2021-11-02 | Integrated Micro-Chromatography Systems, Inc. | Dispersive pipette extraction system for purification of large biomolecules |
| GB201704768D0 (en) * | 2017-01-05 | 2017-05-10 | Illumina Inc | Flow cell liquid degassing systema and method |
| CN106701556B (en) * | 2017-01-06 | 2019-02-12 | 广东顺德永诺生物科技有限公司 | Digital pcr detection device and its liquid channel system |
| CN108929841A (en) * | 2017-05-25 | 2018-12-04 | 菏泽学院 | The manual producing device of animal physiological experiment plasmid DNA samples |
| JP7209374B2 (en) * | 2017-08-02 | 2023-01-20 | ポカード・ディアグノスティクス・リミテッド | A processor filter arrangement including a method and apparatus for removing waste fluid through a filter |
| CN108130325A (en) * | 2018-02-02 | 2018-06-08 | 苏州优卡新材料科技有限公司 | A kind of efficiently purifying column of ribonucleic acid extraction inorganic material filter core |
| KR102136695B1 (en) * | 2018-08-22 | 2020-07-22 | 주식회사 인퓨전텍 | Method for pathogen enrichment and nucleic acid extract using device for point of care testing |
| KR101996617B1 (en) * | 2018-10-11 | 2019-07-04 | 주식회사 엘지화학 | Integrated cartridge |
| US10864483B2 (en) * | 2018-11-16 | 2020-12-15 | Integrated Protein Technologies, Snc. | Molecular weight filtration system and apparatus |
| GB2581489B (en) * | 2019-02-15 | 2021-02-24 | Revolugen Ltd | Purification method |
| US11591591B2 (en) | 2019-08-21 | 2023-02-28 | New England Biolabs, Inc. | Isolation of high molecular weight DNA using beads |
| EP3821979A1 (en) * | 2019-11-18 | 2021-05-19 | Miltenyi Biotec B.V. & Co. KG | Enhanced process for sorting cells with a microfabricated valve |
| CA3192080A1 (en) | 2020-09-18 | 2022-03-24 | Marc DEJOHN | Portable devices and methods for analyzing samples |
| CN114618849B (en) * | 2020-12-11 | 2023-07-18 | 深圳市帝迈生物技术有限公司 | Cleaning device, cleaning method and sample analysis device for magnetic separation reaction cup |
| CN112807825A (en) * | 2020-12-31 | 2021-05-18 | 上海金鑫生物科技有限公司 | High-flux automatic opening and closing type filtering suction head |
| KR102562639B1 (en) * | 2021-04-29 | 2023-08-02 | 주식회사 한국과학 | Sample taking and diagnosing method for pcr(polymerase chain reaction) diagnosis and sample taking tool for pcr diagnosis |
| CN116371259B (en) * | 2023-06-06 | 2023-08-01 | 南宫市喀秋莎润滑油科技有限公司 | Mixed blending machine for lubricating oil production |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1117601A (en) * | 1913-05-09 | 1914-11-17 | Gen Filtration Company Inc | Filtering medium. |
| US2114748A (en) * | 1934-05-09 | 1938-04-19 | Firm Jenaer Glaswerk Schott & | Method of making porous filter bodies of particles of glass |
| US3414394A (en) * | 1965-06-21 | 1968-12-03 | Owens Illinois Inc | Sintered glass article and method of making |
| DE3037898A1 (en) * | 1980-10-07 | 1982-05-06 | Bruker Analytische Meßtechnik GmbH, 7512 Rheinstetten | MIXING CHAMBER |
| US4475818A (en) * | 1983-08-25 | 1984-10-09 | Bialkowski Wojciech L | Asphalt coating mix automatic limestone control |
| US4774058A (en) * | 1985-09-26 | 1988-09-27 | Mehl Ehrenfried L | Apparatus for, and methods of, operating upon a fluid |
| DE3635598A1 (en) * | 1986-10-20 | 1988-05-05 | Eppendorf Geraetebau Netheler | PIPETTING DEVICE WITH A CLIP-ON CONE FOR A PIPETTE TIP AND PIPETTE TIP FOR SUCH A PIPETTING DEVICE |
| US4765818A (en) | 1987-02-24 | 1988-08-23 | Hoechst Celanese Corporation | Porous glass monoliths |
| US4810674A (en) * | 1987-02-24 | 1989-03-07 | Hoechst Celanese Corp. | Porous glass monoliths |
| US4912034A (en) | 1987-09-21 | 1990-03-27 | Biogenex Laboratories | Immunoassay test device and method |
| US4923978A (en) | 1987-12-28 | 1990-05-08 | E. I. Du Pont De Nemours & Company | Process for purifying nucleic acids |
| IT1240870B (en) * | 1990-02-14 | 1993-12-17 | Talent | PROCEDURE FOR THE EXTRACTION AND PURIFICATION OF HUMAN GENOMIC DNA |
| DE4139664A1 (en) * | 1991-12-02 | 1993-06-03 | Diagen Inst Molekularbio | DEVICE AND METHOD FOR ISOLATING AND CLEANING NUCLEIC ACIDS |
| CA2105962A1 (en) * | 1992-09-18 | 1994-03-19 | Margaret Patricia Raybuck | Device and method for affinity separation |
| EP0688426A1 (en) * | 1993-03-08 | 1995-12-27 | WAINWRIGHT, Norman | Aligned fiber diagnostic chromatography |
| DE4321904B4 (en) * | 1993-07-01 | 2013-05-16 | Qiagen Gmbh | Method for chromatographic purification and separation of nucleic acid mixtures |
| DE59502334D1 (en) * | 1994-01-07 | 1998-07-02 | Qiagen Gmbh | METHOD FOR CRUSHING HIGH MOLECULAR STRUCTURES |
| DE4432654C2 (en) * | 1994-09-14 | 1998-03-26 | Qiagen Gmbh | Process for the isolation of nucleic acids from natural sources |
| US5496523A (en) * | 1994-05-06 | 1996-03-05 | Sorenson Bioscience | Filtered micropipette tip for high/low volume pipettors |
| DE19530132C2 (en) * | 1995-08-16 | 1998-07-16 | Max Planck Gesellschaft | Process for the purification, stabilization or isolation of nucleic acids from biological materials |
| EP1736554B1 (en) * | 1996-05-29 | 2013-10-09 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| US6074827A (en) * | 1996-07-30 | 2000-06-13 | Aclara Biosciences, Inc. | Microfluidic method for nucleic acid purification and processing |
| US6048457A (en) * | 1997-02-26 | 2000-04-11 | Millipore Corporation | Cast membrane structures for sample preparation |
| US6337214B1 (en) * | 1997-06-09 | 2002-01-08 | Acgt Medico, Inc. | Detection of DNA, RNA and proteins using a test column with two snares |
| JPH11266864A (en) * | 1998-03-19 | 1999-10-05 | Hitachi Ltd | Purification of nucleic acid and device for purification |
| AU6114199A (en) * | 1998-10-09 | 2000-05-01 | Whatman Bioscience Limited | Isolation method for nucleic acid and apparatus |
| US6958392B2 (en) * | 1998-10-09 | 2005-10-25 | Whatman, Inc. | Methods for the isolation of nucleic acids and for quantitative DNA extraction and detection for leukocyte evaluation in blood products |
| US6100084A (en) * | 1998-11-05 | 2000-08-08 | The Regents Of The University Of California | Micro-sonicator for spore lysis |
| US6431476B1 (en) * | 1999-12-21 | 2002-08-13 | Cepheid | Apparatus and method for rapid ultrasonic disruption of cells or viruses |
| EP1141234A4 (en) | 1999-01-06 | 2004-05-19 | Invitrogen Corp | Methods and compositions for isolation of nucleic acid molecules |
| CA2374423C (en) * | 1999-05-28 | 2013-04-09 | Cepheid | Apparatus and method for analyzing a liquid sample |
| GB9913275D0 (en) * | 1999-06-08 | 1999-08-04 | Dna Research Instr Limited | Sample processing device |
| DE19962577A1 (en) | 1999-12-23 | 2001-07-12 | Tittgen Biotechnologie Dr | Chromatography material and method using the same |
| US6699713B2 (en) * | 2000-01-04 | 2004-03-02 | The Regents Of The University Of California | Polymerase chain reaction system |
| GB0011443D0 (en) * | 2000-05-13 | 2000-06-28 | Dna Research Instr Limited | Separation device |
| US6537502B1 (en) * | 2000-07-25 | 2003-03-25 | Harvard Apparatus, Inc. | Surface coated housing for sample preparation |
| JP3752417B2 (en) * | 2000-09-07 | 2006-03-08 | 株式会社日立製作所 | Nucleic acid purification method and purification apparatus |
| US7157232B2 (en) * | 2000-12-13 | 2007-01-02 | The Regents Of The University Of California | Method to detect the end-point for PCR DNA amplification using an ionically labeled probe and measuring impedance change |
| WO2002078847A1 (en) * | 2001-03-28 | 2002-10-10 | Hitachi, Ltd. | Instrument and method for recovering nucleic acid |
| US20030138819A1 (en) * | 2001-10-26 | 2003-07-24 | Haiqing Gong | Method for detecting disease |
| US20050092685A1 (en) * | 2002-01-17 | 2005-05-05 | Spark Holland B.V. | Set comprising a pipette and a cartridge, as well as a method for applying a sample to the cartridge and an analytical method |
| US20040054160A1 (en) * | 2002-09-16 | 2004-03-18 | Santona Pal | Nucleic-acid ink compositions for arraying onto a solid support |
| DE112004000843B4 (en) * | 2003-05-29 | 2015-01-29 | Agilent Technologies, Inc. | Solid phase extraction device |
| US7722820B2 (en) * | 2004-11-19 | 2010-05-25 | Phynexus, Inc. | Method and device for sample preparation |
| EP1498492B1 (en) * | 2003-07-15 | 2011-11-02 | Lukas Bestmann | Apparatus for the preparation of samples |
| US7541166B2 (en) * | 2003-09-19 | 2009-06-02 | Microfluidic Systems, Inc. | Sonication to selectively lyse different cell types |
| US20050136477A1 (en) * | 2003-11-17 | 2005-06-23 | Hashem Akhavan-Tafti | Methods for isolating nucleic acids from biological and cellular materials |
| US8586350B2 (en) * | 2004-02-12 | 2013-11-19 | Gl Sciences Incorporated | Mechanism of separating and purifying DNA and the like |
| EA010202B1 (en) * | 2004-06-09 | 2008-06-30 | Пэтоджен Римувал Энд Дайэгностик Текнолоджиз Инк. | Device and method for removing target agents from a sample |
| US7615347B2 (en) * | 2004-08-20 | 2009-11-10 | Asahi Kasei Kabushiki Kaisha | Method for trapping nucleic acids using divalent metal ions |
| DE102005005437A1 (en) * | 2005-02-05 | 2006-08-10 | Eppendorf Ag | Filter pipette tip |
| JP2006246732A (en) * | 2005-03-09 | 2006-09-21 | Kanto Chem Co Inc | Nucleic acid purification supporter and method for purifying the same |
| KR100657957B1 (en) * | 2005-04-12 | 2006-12-14 | 삼성전자주식회사 | 1 Method for isolating a nucleic acid using a material positively charged at the first pH and comprising an amino group and a carboxyl group and a solid material for a nucleic acid purification capable of being used for the method |
| JP4791750B2 (en) * | 2005-04-15 | 2011-10-12 | ジーエルサイエンス株式会社 | Separation and purification method and separation and purification mechanism for DNA, etc. |
| JP5240965B2 (en) * | 2005-09-02 | 2013-07-17 | 愛知県 | Method and apparatus for analyzing sulfated glycolipid |
| JP4699868B2 (en) * | 2005-11-04 | 2011-06-15 | 株式会社日立ハイテクノロジーズ | Nucleic acid purification method and nucleic acid purification instrument |
| JP2007155518A (en) * | 2005-12-06 | 2007-06-21 | Showa Denko Kk | Solid phase extraction cartridge |
| DE102006002258B4 (en) * | 2006-01-17 | 2008-08-21 | Siemens Ag | Module for the preparation of a biological sample, biochip set and use of the module |
| US8686129B2 (en) * | 2007-03-20 | 2014-04-01 | Agilent Technologies, Inc. | Methods for the separation of biological molecules using sulfolane |
| US20080146789A1 (en) * | 2007-03-20 | 2008-06-19 | Braman Jeffrey C | Methods for the separation of biological molecules using dioxolane |
| US10300482B2 (en) * | 2010-12-09 | 2019-05-28 | Akonni Biosystems, Inc. | Sample analysis system |
| US20090111193A1 (en) * | 2007-10-31 | 2009-04-30 | Cooney Christopher G | Sample preparation device |
| US7759112B2 (en) | 2007-10-31 | 2010-07-20 | Akonni Biosystems, Inc. | Apparatus, system, and method for purifying nucleic acids |
-
2007
- 2007-10-31 US US11/933,113 patent/US7759112B2/en active Active
-
2008
- 2008-03-11 WO PCT/US2008/056482 patent/WO2009058414A1/en active Application Filing
- 2008-03-11 EP EP08731876.2A patent/EP2215103B1/en active Active
- 2008-03-11 CA CA2703950A patent/CA2703950C/en not_active Expired - Fee Related
- 2008-03-11 JP JP2010531081A patent/JP5977921B2/en active Active
- 2008-03-11 CN CN200880116501.9A patent/CN101883776B/en active Active
- 2008-06-25 EP EP08780985.1A patent/EP2217344B1/en active Active
- 2008-06-25 JP JP2010531085A patent/JP5318110B2/en active Active
- 2008-06-25 WO PCT/US2008/068159 patent/WO2009058432A1/en active Application Filing
- 2008-06-25 CN CN2008801191314A patent/CN101883619B/en active Active
- 2008-06-25 CA CA2704771A patent/CA2704771C/en active Active
-
2010
- 2010-06-03 US US12/793,218 patent/US8236501B2/en active Active
- 2010-06-03 US US12/793,253 patent/US8236553B2/en active Active
-
2011
- 2011-04-28 HK HK11104271.9A patent/HK1150166A1/en not_active IP Right Cessation
-
2012
- 2012-07-03 US US13/541,353 patent/US20120283423A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101883776B (en) | 2014-04-02 |
| US20100240123A1 (en) | 2010-09-23 |
| EP2217344B1 (en) | 2023-01-04 |
| EP2217344A1 (en) | 2010-08-18 |
| EP2215103B1 (en) | 2019-08-07 |
| US7759112B2 (en) | 2010-07-20 |
| WO2009058432A1 (en) | 2009-05-07 |
| EP2215103A1 (en) | 2010-08-11 |
| JP2011502251A (en) | 2011-01-20 |
| CA2704771A1 (en) | 2009-05-07 |
| JP5977921B2 (en) | 2016-08-24 |
| US20090107927A1 (en) | 2009-04-30 |
| EP2217344A4 (en) | 2016-03-09 |
| US8236553B2 (en) | 2012-08-07 |
| CN101883619A (en) | 2010-11-10 |
| JP5318110B2 (en) | 2013-10-16 |
| CA2703950A1 (en) | 2009-05-07 |
| EP2215103A4 (en) | 2014-07-23 |
| CN101883619B (en) | 2013-08-07 |
| US20100240882A1 (en) | 2010-09-23 |
| US8236501B2 (en) | 2012-08-07 |
| WO2009058414A1 (en) | 2009-05-07 |
| CA2703950C (en) | 2018-06-12 |
| CN101883776A (en) | 2010-11-10 |
| HK1150166A1 (en) | 2011-11-04 |
| US20120283423A1 (en) | 2012-11-08 |
| JP2011505118A (en) | 2011-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2704771C (en) | Sample preparation device | |
| US8574923B2 (en) | Sample preparation device | |
| US20120071643A1 (en) | System and methods for purifying biological materials | |
| JP6800144B2 (en) | Nucleic acid purification cartridge | |
| JP4020917B2 (en) | Vacuum assisted affinity chromatography apparatus and method | |
| US20240082838A1 (en) | Nucleic acid extraction and purification cartridges | |
| JP4225972B2 (en) | Microfluidic device and method comprising a purification column with excess diluent | |
| WO1998037949A1 (en) | Cast membrane structures for sample preparation | |
| KR102491723B1 (en) | Microfluidic devices and nucleic acid analysis methods | |
| KR20160145610A (en) | Method and apparatus for purifying biological molecules | |
| US20080272053A1 (en) | Combinatorial separations and chromatography renewable microcolumn | |
| CN114502250A (en) | Methods and compositions for sample filtration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20130620 |